FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable products. In addition, it engages in research and development, storage, and cryopreservation of sperm and oocytes for use in reproductive medicine; and the manufacturing and distribution of medical devices. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is headquartered in Leipzig, Germany.
Часто задаваемые вопросы
В каком секторе работает VITA 34 AG (V3V)?
VITA 34 AG относится к сектору Здравоохранение.
Какова текущая цена акций VITA 34 AG (V3V)?
По последним данным, цена акций VITA 34 AG составляет 2,71 €, предыдущее закрытие — 2,71 €.
Выплачивает ли VITA 34 AG (V3V) дивиденды?
Нет, VITA 34 AG не выплачивает дивиденды.
Какой бета-коэффициент (волатильность) у VITA 34 AG (V3V)?
У компании VITA 34 AG бета 0.623, что указывает на более низкую волатильность по сравнению с рынком в целом.
